Phenotypic Expression of Autoimmunity in Children With Autoimmune Thyroid Disorders.

Graves' disease Hashimoto's thyroiditis additional autoimmunity extra-thyroidal autoimmunity metamorphic autoimmunity

Journal

Frontiers in endocrinology
ISSN: 1664-2392
Titre abrégé: Front Endocrinol (Lausanne)
Pays: Switzerland
ID NLM: 101555782

Informations de publication

Date de publication:
2019
Historique:
received: 26 02 2019
accepted: 01 07 2019
entrez: 30 7 2019
pubmed: 30 7 2019
medline: 30 7 2019
Statut: epublish

Résumé

Autoimmune thyroid diseases (AITDs), including Hashimoto's thyroiditis (HT) and Graves' disease (GD), tend to aggregate with other non-thyroidal autoimmune diseases (NTADs). Aim of this Mini-review is to report the most recent insights concerning the clustering of NTADs in pediatric patients with either HT or GD, the pathophysiology of AITDs and the metamorphic thyroid autoimmunity. A systematic literature research of the last 15 years, according to EQUATOR statement, was carried out through MEDLINE via PubMed (http://www.ncbi.nlm.nih.gov/pubmed/) Embase, CINAHL, Cochrane Library, based on the following keywords: (autoimmune thyroid disease OR Hashimoto thyroiditis OR Grave's disease) AND (autoimmune comorbidities OR extra-thyroidal autoimmune disorders) AND (children OR adolescents OR pediatrics) AND (celiac disease OR type 1 diabetes mellitus OR arthropathies OR cutaneous diseases) AND (Turner syndrome OR Down syndrome). One-hundred and twenty-eight manuscripts were extrapolated but only seventeen were eligible. On the basis of the available reports it may be inferred that clustering of NTADs can be significantly modified by both patients' age at AITDs presentation and association with Down's syndrome (DS). Particularly, the association of AITDs with celiac disease and type 1 diabetes was most commonly reported in children than in adults. A sequential shifting from HT to GD has been described in children with AITDs, and it seems to be more frequent in children with DS than in those without DS. Coexistence of autoimmune diseases might be the result of a complex interaction among genetics, environment and epigenetic modifications that are able to affect gene expression, immune system response and, finally, the pathogenesis of autoimmune diseases.

Identifiants

pubmed: 31354636
doi: 10.3389/fendo.2019.00476
pmc: PMC6640617
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

476

Références

J Clin Endocrinol Metab. 2002 Dec;87(12):5385-97
pubmed: 12466323
Eur J Hum Genet. 2003 Jan;11(1):81-4
pubmed: 12529710
Nature. 2003 May 29;423(6939):506-11
pubmed: 12724780
J Clin Endocrinol Metab. 2006 Mar;91(3):1087-92
pubmed: 16352685
Eur J Endocrinol. 2006 Jan;154(1):13-20
pubmed: 16381986
Pediatr Int. 2006 Aug;48(4):433-5
pubmed: 16911096
Endocrinology. 2007 Dec;148(12):5724-33
pubmed: 17823263
Clin Gastroenterol Hepatol. 2008 Jul;6(7):753-8
pubmed: 18255352
J Clin Endocrinol Metab. 2008 Oct;93(10):3915-21
pubmed: 18611971
Pediatr Diabetes. 2008 Aug;9(4 Pt 2):423-5
pubmed: 18775001
Thyroid. 2008 Oct;18(10):1035-7
pubmed: 18844474
J Endocrinol Invest. 2010 Mar;33(3):202-3
pubmed: 19574731
PLoS Med. 2009 Jul 21;6(7):e1000097
pubmed: 19621072
J Autoimmun. 2009 Nov-Dec;33(3-4):197-207
pubmed: 19819109
Eur J Endocrinol. 2010 Mar;162(3):591-5
pubmed: 19955260
Am J Med. 2010 Feb;123(2):183.e1-9
pubmed: 20103030
Arthritis Rheum. 2010 Mar;62(3):658-66
pubmed: 20187158
Horm Res Paediatr. 2010;73(6):473-6
pubmed: 20395669
Mini Rev Med Chem. 2010 Aug;10(9):846-55
pubmed: 20482499
Evid Based Med. 2010 Oct;15(5):158-9
pubmed: 20667903
Clin Endocrinol (Oxf). 2011 Apr;74(4):411-8
pubmed: 20718761
Metabolism. 2011 Jun;60(6):761-6
pubmed: 20825955
J Am Geriatr Soc. 2010 Aug;58(8):1565-75
pubmed: 20942872
J Pediatr. 2011 Feb;158(2):272-5.e1
pubmed: 20961564
Horm Res Paediatr. 2011;75(3):157-65
pubmed: 21346360
Eur J Endocrinol. 2011 May;164(5):789-94
pubmed: 21378091
Clin Pediatr (Phila). 2011 Nov;50(11):1040-4
pubmed: 21700620
Horm Res Paediatr. 2011;76(4):221-5
pubmed: 21811047
Arch Dis Child. 2011 Nov;96(11):1038-41
pubmed: 21862521
Horm Res Paediatr. 2012;77(1):36-40
pubmed: 22286076
Horm Res Paediatr. 2012;78(4):232-6
pubmed: 23128840
Diabetes Care. 2013 May;36(5):1181-5
pubmed: 23275362
Ital J Pediatr. 2013 Jan 30;39:8
pubmed: 23363471
BMC Med. 2013 Mar 18;11:73
pubmed: 23497011
Aging Cell. 2013 Oct;12(5):873-81
pubmed: 23755918
J Pediatr Gastroenterol Nutr. 2013 Oct;57(4):467-71
pubmed: 23863325
Annu Rev Pathol. 2014;9:147-56
pubmed: 24460189
J Endocrinol Invest. 2014 Mar;37(3):303-8
pubmed: 24474680
Horm Res Paediatr. 2014;81(4):245-50
pubmed: 24504143
Autoimmune Dis. 2014;2014:417356
pubmed: 24592326
Eur J Endocrinol. 2014 Jun;170(6):R241-52
pubmed: 24609834
Endocr Metab Immune Disord Drug Targets. 2014;14(3):182-6
pubmed: 24965722
J Immunol. 2014 Sep 1;193(5):2187-95
pubmed: 25038256
J Immunol. 2014 Oct 15;193(8):3872-9
pubmed: 25217160
Endocrine. 2015 Dec;50(3):777-82
pubmed: 25542186
Ital J Pediatr. 2015 May 15;41:39
pubmed: 25971674
Hormones (Athens). 2015 Jul-Sep;14(3):410-6
pubmed: 26188225
J Autoimmun. 2015 Nov;64:82-90
pubmed: 26235382
Diabetes Res Clin Pract. 2015 Oct;110(1):e9-e11
pubmed: 26238236
Pediatr Nurs. 2015 Mar-Apr;41(2):89-91
pubmed: 26292458
Eur J Endocrinol. 2015 Dec;173(6):801-8
pubmed: 26374873
Ital J Pediatr. 2015 Nov 11;41:87
pubmed: 26558364
Dig Liver Dis. 2016 May;48(5):499-505
pubmed: 26854256
J Pediatr. 2016 Jul;174:146-152.e1
pubmed: 27021409
J Pediatr Endocrinol Metab. 2016 Sep 1;29(9):1041-6
pubmed: 27442363
Autoimmun Rev. 2016 Dec;15(12):1125-1128
pubmed: 27639841
Horm Res Paediatr. 2016;86(6):403-409
pubmed: 27866202
Eur J Endocrinol. 2017 Feb;176(2):133-141
pubmed: 27913607
Eur J Endocrinol. 2017 Sep;177(3):G1-G70
pubmed: 28705803
Front Endocrinol (Lausanne). 2017 Jun 29;8:149
pubmed: 28706507
Arch Argent Pediatr. 2018 Feb 1;116(1):56-58
pubmed: 29333819
Front Endocrinol (Lausanne). 2018 Sep 13;9:540
pubmed: 30271383
Autoimmun Rev. 2019 Mar;18(3):287-292
pubmed: 30639646

Auteurs

Tommaso Aversa (T)

Department of Human Pathology of Adulthood and Childhood, Unit of Pediatrics, University of Messina, Messina, Italy.

Domenico Corica (D)

Department of Human Pathology of Adulthood and Childhood, Unit of Pediatrics, University of Messina, Messina, Italy.

Giuseppina Zirilli (G)

Department of Human Pathology of Adulthood and Childhood, Unit of Pediatrics, University of Messina, Messina, Italy.

Giovanni Battista Pajno (GB)

Department of Human Pathology of Adulthood and Childhood, Unit of Pediatrics, University of Messina, Messina, Italy.

Giuseppina Salzano (G)

Department of Human Pathology of Adulthood and Childhood, Unit of Pediatrics, University of Messina, Messina, Italy.

Filippo De Luca (F)

Department of Human Pathology of Adulthood and Childhood, Unit of Pediatrics, University of Messina, Messina, Italy.

Malgorzata Wasniewska (M)

Department of Human Pathology of Adulthood and Childhood, Unit of Pediatrics, University of Messina, Messina, Italy.

Classifications MeSH